Response to Comment on: “Targeted anti-cancer agents and risk of venous thromboembolism” by Melina Verso, Florian Moik, Mara Graziani, Alexander T. Cohen

Get full text

Arterial and venous thromboembolic events in patients with cancer treated with targeted therapies: a population-based cohort studyResearch in context by Florian Moik, Erzsébet Horváth-Puhó, Cihan Ay, Ingrid Pabinger, Frits Mulder, Nick van Es, Henrik Toft Sørensen

Get full text

Validation of risk assessment models for venous thromboembolism in patients with cancer receiving systemic therapies by Nikola Vladić, Cornelia Englisch, Julia M. Berger, Florian Moik, Anna S. Berghoff, Matthias Preusser, Ingrid Pabinger, Cihan Ay

Get full text

Longitudinal dynamics of hemostatic biomarkers in patients with cancer receiving immune checkpoint inhibitors vs chemotherapy: results from the Vienna CAT-BLED study by Nikola Vladic, Cornelia Englisch, Julia Maria Berger, Florian Moik, Hubert Hayden, Johannes Thaler, Anna Sophie Berghoff, Thorsten Fuereder, Matthias Preusser, Ingrid Pabinger, Cihan Ay

Get full text